Early diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy.

MLA

Gillingham, Melanie B., et al. “Early Diagnosis and Treatment by Newborn Screening (NBS) or Family History Is Associated with Improved Visual Outcomes for Long-Chain 3-HydroxyacylCoA Dehydrogenase Deficiency (LCHADD) Chorioretinopathy.” Journal of Inherited Metabolic Disease, vol. 47, no. 4, July 2024, pp. 746–56. EBSCOhost, https://doi.org/10.1002/jimd.12738.

APA

Gillingham, M. B., Choi, D., Gregor, A., Wongchaisuwat, N., Black, D., Scanga, H. L., Nischal, K. K., Sahel, J.-A., Arnold, G., Vockley, J., Harding, C. O., & Pennesi, M. E. (2024). Early diagnosis and treatment by newborn screening (NBS) or family history is associated with improved visual outcomes for long-chain 3-hydroxyacylCoA dehydrogenase deficiency (LCHADD) chorioretinopathy. Journal of Inherited Metabolic Disease, 47(4), 746–756. https://doi.org/10.1002/jimd.12738

Chicago

Gillingham, Melanie B, Dongseok Choi, Ashley Gregor, Nida Wongchaisuwat, Danielle Black, Hannah L Scanga, Ken K Nischal, et al. 2024. “Early Diagnosis and Treatment by Newborn Screening (NBS) or Family History Is Associated with Improved Visual Outcomes for Long-Chain 3-HydroxyacylCoA Dehydrogenase Deficiency (LCHADD) Chorioretinopathy.” Journal of Inherited Metabolic Disease 47 (4): 746–56. doi:10.1002/jimd.12738.